| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2002 | US6348470 Alleviate cough with theobromine |
| 02/19/2002 | US6348469 Solid compositions containing glipizide and polyethylene oxide |
| 02/19/2002 | US6348468 Pyridazine compounds and compositions containing the same |
| 02/19/2002 | US6348467 Antitumor agent from animal extracts |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348465 Treating diabetes with enzyme inhibitors |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348459 Sultam and sultone derived oxazolidinones |
| 02/19/2002 | US6348457 Antagonizing reserpine in mammals |
| 02/19/2002 | US6348456 Method of treating chemical dependency in mammals and a composition therefor |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/19/2002 | US6348452 Microbiocides, bactericides for gastrointestinal disorders in animals |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348312 Oligonucleotide having length of 6-100 nucleotides, wherein at least one non-terminal pyrimidine nucleoside is modified, and also 5' and/or 3' ends are modified, by replacement of 3' and/or 5' phosphodiester bridge by phosphorothioate bridge |
| 02/19/2002 | US6348229 Food comprising thixotropic composition of unsaturated fat and process for manufacture thereof |
| 02/19/2002 | US6348220 Composition comprising macerated plant seeds, comprising phenethylisothiocyanate in amount of at least 2 milligrams per gram fresh weight of plant seed preparation |
| 02/19/2002 | US6348216 Ibuprofen and narcotic analgesic compositions |
| 02/19/2002 | US6348213 Intravenously administering liposomes having lipid component comprising phosphatidylcholine having same acyl chains as phosphatidylcholines in heart cells of younger subjects, repeating until drop in serum creatine phosphokinase is noted |
| 02/19/2002 | US6348211 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 02/19/2002 | US6348209 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm |
| 02/19/2002 | US6348208 Methods and pharmaceutical compositions employing desmethylselegiline |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | US6348203 Antimicrobial metronidazole and tinidizole in suspension with a polysaccharide, a water miscible alkylene glycolsolvent and water; hydrogel that is less prone to irritate inflamed or sensitive skin |
| 02/19/2002 | US6348194 Tumor specific internalizing antigens and methods for targeting therapeutic agents |
| 02/19/2002 | US6348190 Pharmaceutical compositions with antimicrobial activity |
| 02/19/2002 | US6347633 Treatment of hepatitis C using hyperthermia |
| 02/19/2002 | US6347443 Method of making a hollow-tube precursor brachytherapy device |
| 02/19/2002 | CA2229786C Zwitterionic forms of trovafloxacin |
| 02/19/2002 | CA2217948C Metered dose inhaler for fluticasone propionate |
| 02/19/2002 | CA2204604C Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 02/19/2002 | CA2203274C Apolipoprotein-b synthesis inhibitors |
| 02/19/2002 | CA2195065C Inhalation composition |
| 02/19/2002 | CA2182030C Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition; composition thus obtained |
| 02/19/2002 | CA2165118C Cosmetic or dermatologic composition containing a ceramide mixture; use thereof for skin moisturizing |
| 02/19/2002 | CA2112083C Aryl substituted heterocyclic compounds |
| 02/19/2002 | CA2087274C 4-alkylimidazole derivatives |
| 02/19/2002 | CA2082568C Amorphous (quinolin-2-ylmethoxy) indoles |
| 02/19/2002 | CA2024040C Dibenz [b,f] [1,4]oxazepin (and thiazepin)-11 (10h)-ones and-thiones and their use in the prevention or treatment of aids |
| 02/19/2002 | CA2023630C Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/19/2002 | CA2004461C Method for the stimulation of bone marrow cells |
| 02/18/2002 | CA2355411A1 Combination therapy using sympathetic nervous system antagonists and endothelin antagonists |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/16/2002 | CA2354639A1 Method of making tablets and tablet compositions produced therefrom |
| 02/14/2002 | WO2002070513A1 Methods for the preparation of mirtazapine intermediates |
| 02/14/2002 | WO2002012565A1 Association of sim2 with cancer |
| 02/14/2002 | WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012444A2 Amniotic apoptosis modulating substances |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012421A1 Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 02/14/2002 | WO2002012348A2 Isolation of glucan particles and uses thereof |
| 02/14/2002 | WO2002012347A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012288A2 Vaccination against host cell-associated herpesviruses |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012281A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 02/14/2002 | WO2002012270A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | WO2002012260A1 Macrolide antibiotics |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012248A1 Avermectin derivatives |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012240A1 Derivatives of variolin b |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012234A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012233A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012232A1 Tartrate salt of thiazolidinedione derivative |
| 02/14/2002 | WO2002012231A1 Tartrate salts of thiazolidinedione derivative |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012225A1 Salts of benzimidazole compound and use thereof |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012223A2 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/14/2002 | WO2002012218A1 N-methyl-d-aspartate receptor antagonists |
| 02/14/2002 | WO2002012217A1 New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments |
| 02/14/2002 | WO2002012215A1 Process for the preparation of baccatin iii derivatives |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012194A1 Phenantridine derivatives and their use as anti-telomerase agent |
| 02/14/2002 | WO2002012192A1 Quinolene derivatives as anti-inflammation agents |
| 02/14/2002 | WO2002012191A1 Cyclic amine derivatives and use thereof |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |